|
Volumn 8, Issue 12, 2003, Pages 518-519
|
Custom-made vaccines at speed
a
a
NONE
|
Author keywords
Biochemistry; Cell biology; Drug Discovery; Influenza; Molecular Medicine; Reverse genetics; SARS; Speed; Vaccine
|
Indexed keywords
COMPLEMENTARY DNA;
GLYCOPROTEIN;
HEMAGGLUTININ;
INACTIVATED VIRUS VACCINE;
NEUTRALIZING ANTIBODY;
SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;
SIALIDASE;
UNCLASSIFIED DRUG;
VIRUS ENVELOPE PROTEIN;
CORONAVIRUS;
DRUG EFFICACY;
EPIDEMIC;
GENE MUTATION;
GENE THERAPY;
GENETIC ENGINEERING;
HUMAN;
INFLUENZA VIRUS;
MOLECULAR CLONING;
NONHUMAN;
PARAINFLUENZA VIRUS;
PATHOGENESIS;
PATHOGENICITY;
PLASMID;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
RNA VIRUS;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
SHORT SURVEY;
VACCINE PRODUCTION;
VIRUS GENOME;
VIRUS ISOLATION;
VIRUS PNEUMONIA;
VIRUS STRAIN;
HUMANS;
INFLUENZA VACCINES;
SEVERE ACUTE RESPIRATORY SYNDROME;
TECHNOLOGY, PHARMACEUTICAL;
VIRAL VACCINES;
|
EID: 0038799794
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(03)02741-7 Document Type: Short Survey |
Times cited : (3)
|
References (4)
|